Magnetic bead purification kits market seen reaching $8.64 billion by 2030

The magnetic bead purification kits market is projected to grow from $4.08 billion in 2025 to $8.64 billion by 2030, driven by rising infectious disease testing, biotech research and laboratory automation. North America held the largest regional share in 2025 as demand grows for faster, higher-purity biomolecule isolation.

Why it matters: - Magnetic bead purification kits are becoming a core lab tool as biotech, diagnostics and pharmaceutical workflows move toward faster and more automated biomolecule purification. - The market’s projected jump to $8.64 billion by 2030 signals sustained demand for DNA, RNA and protein isolation technologies. - Rising infectious disease testing adds another layer of demand for accurate sample preparation and molecular diagnostics.

What happened: - The Business Research Company estimated the magnetic bead purification kits market at $4.08 billion in 2025 and $4.75 billion in 2026. - The market is forecast to reach $8.64 billion by 2030, implying a 16.1% compound annual growth rate from 2026 to 2030. - The company said the market’s 2025-2026 growth reflects a 16.4% compound annual growth rate. - North America held the largest share of the market in 2025. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The Business Research Company also published a free sample report and the full market report online: the free sample and the full report.

The details: - Magnetic bead purification kits use coated magnetic beads to bind target biomolecules such as proteins, DNA, RNA or cells from complex mixtures. - The kits are designed to improve speed, precision and selectivity while reducing hands-on labor. - Historical market growth was tied to manual membrane column-based kits, limited standardized reagents, rising biotechnology research, stronger diagnostic testing demand and greater awareness of nucleic acid purification. - Future growth is expected to come from semi-automated purification systems, expanding genomics and proteomics research, higher pharmaceutical and diagnostic use, stricter regulatory compliance and integration with high-throughput laboratory automation. - Key trends include stronger demand for high-purity DNA, RNA and protein isolation, wider use of semi-automated magnetic bead kits, growth in academic and pharmaceutical research, expanding miRNA purification in diagnostics and faster workflows with less manual handling. - North America’s lead is tied to strong biotechnology infrastructure, high healthcare spending and substantial research funding.

Between the lines: - The market forecast points to a broader shift in life sciences toward standardized, automation-friendly sample prep tools. - Infectious disease pressure and molecular testing needs are reinforcing demand for kits that can deliver reproducible results with less labor. - The report frames magnetic bead purification as a supporting technology that benefits from growth in genomics, proteomics and clinical diagnostics rather than from a single end market. - GOV.UK reported in February 2024 that TB cases in England rose 10.7% in 2023, from 4,380 in 2022 to 4,850.

What's next: - The market is expected to keep expanding through 2030 as laboratories adopt semi-automated and high-throughput systems. - Growth should continue in research, diagnostics and pharmaceutical applications as demand rises for cleaner and faster biomolecule isolation. - The Business Research Company said its 2026 report updates include market attractiveness scoring, TAM analysis, company scoring matrices, Excel-based forecasting dashboards, market hotspot infographics and refreshed trend graphics.